
|Videos|June 23, 2015
Benefits of the ACO Model
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
Advertisement
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
2
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
3
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
4
A Closer Look at Interdisciplinary Care with Unit-Based Pharmacy
5


















































































































































































































